40 Stocks Moving In Monday’s Mid-Day Session
Gainers
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.
Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals
Following the market opening Monday, the Dow traded down 0.65% to 35,736.04 while the NASDAQ fell 0.26% to 15,590.13. The S&P also fell, dropping 0.46% to 4,690.48.
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setback For Merck’s HIV Program, Decision Day For Daré
Here's a roundup of top developments in the biotech space over the last 24 hours:
RBC Capital Maintains Outperform on BELLUS Health, Raises Price Target to $11
RBC Capital analyst Gregory Renza maintains BELLUS Health (NASDAQ:BLU) with a Outperform and raises the price target from $9 to $11.
BELLUS Health Q3 EPS $(0.29) Down From $(0.09) YoY, Sales $4.00K Up From $3.00K YoY
BELLUS Health (NASDAQ:BLU) reported quarterly losses of $(0.29) per share. This is a 222.22 percent decrease over losses of $(0.09) per share from the same period last year. The company reported $4.00 thousand in sales
RBC Capital Maintains Outperform on BELLUS Health, Raises Price Target to $9
RBC Capital analyst Gregory Renza maintains BELLUS Health (NASDAQ:BLU) with a Outperform and raises the price target from $8 to $9.
The Daily Biotech Pulse: AbbVie’s Migraine Drug OK’d By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours.
Click here for accessing Benzinga's FDA Calendar
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 28)
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 14)
46 Biggest Movers From Yesterday
Gainers
Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share.
Why BELLUS Health Is Trading Higher Today
BELLUS Health (NASDAQ:BLU) shares are trading higher. The company on Monday announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractor chronic cough. HC Wainwright on Tuesday raised its price target on the stock.